Cite

HARVARD Citation

    Katib, Y. et al. (n.d.). 171 High-Dose-Rate Brachytherapy as Monotherapy for the Treatment of Intermediate Risk Prostate Cancer: Toxicity Results. Radiotherapy and oncology. pp. S73-. [Online]. 
  
Back to record